Year To Quarter End Consolidated Statement Of Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7737865

Concept 2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
46,782,000,000 JPY
45,752,000,000 JPY
Cost of sales
33,532,000,000 JPY
33,202,000,000 JPY
Gross profit (loss)
13,249,000,000 JPY
12,550,000,000 JPY
Selling, general and administrative expenses
Salaries
2,507,000,000 JPY
2,454,000,000 JPY
Depreciation
381,000,000 JPY
274,000,000 JPY
Selling, general and administrative expenses
12,593,000,000 JPY
12,254,000,000 JPY
Operating profit (loss)
656,000,000 JPY
296,000,000 JPY
Non-operating income
Interest income
20,000,000 JPY
21,000,000 JPY
Dividend income
79,000,000 JPY
63,000,000 JPY
Non-operating income
368,000,000 JPY
323,000,000 JPY
Non-operating expenses
Interest expenses
222,000,000 JPY
226,000,000 JPY
Non-operating expenses
382,000,000 JPY
448,000,000 JPY
Ordinary profit (loss)
642,000,000 JPY
172,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
477,000,000 JPY
JPY
Extraordinary income
477,000,000 JPY
JPY
Extraordinary losses
Loss on sale of non-current assets
5,000,000 JPY
JPY
Loss on disaster
36,000,000 JPY
JPY
Extraordinary losses
58,000,000 JPY
55,000,000 JPY
Profit (loss) before income taxes
1,061,000,000 JPY
117,000,000 JPY
Income taxes - current
397,000,000 JPY
69,000,000 JPY
Income taxes - deferred
-197,000,000 JPY
37,000,000 JPY
Income taxes
200,000,000 JPY
107,000,000 JPY
Profit (loss)
861,000,000 JPY
861,000,000 JPY
861,000,000 JPY
861,000,000 JPY
10,000,000 JPY
10,000,000 JPY
10,000,000 JPY
10,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.